{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:33:32Z","timestamp":1792035212312,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T00:00:00Z","timestamp":1592006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jhepr.2020.100139","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T02:46:36Z","timestamp":1592448396000},"page":"100139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Granulocyte colony-stimulating factor for alcoholic hepatitis: A\u00a0systematic review and meta-analysis of randomised controlled trials"],"prefix":"10.1016","volume":"2","author":[{"given":"Astrid","family":"Marot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani K.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Deltenre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2020.100139_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL Clinical Practice Guidelines: management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100139_bib2","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2020.100139_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhepr.2020.100139_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2020.100139_bib5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-related liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100139_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100139_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2020.100139_bib8","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2020.100139_bib9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: a systematic review and network meta-analysis","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2020.100139_bib10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2020.100139_bib11","doi-asserted-by":"crossref","first-page":"e0190823","DOI":"10.1371\/journal.pone.0190823","article-title":"Liver transplantation for alcoholic hepatitis: a systematic review with meta-analysis","volume":"13","author":"Marot","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2020.100139_bib12","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cgh.2018.01.040","article-title":"Efficacy of granulocyte colony-stimulating factor and N-acetylcysteine therapies in patients with severe alcoholic hepatitis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2020.100139_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100139_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/SLA.0b013e3181f4e479","article-title":"Stem cell mobilization is life saving in an animal model of acute liver failure","volume":"252","author":"Mark","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2020.100139_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1665-2681(19)30757-4","article-title":"Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis","volume":"14","author":"Chavez-Tapia","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2020.100139_bib16","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3748\/wjg.v19.i7.1104","article-title":"Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure","volume":"19","author":"Duan","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100139_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"Garg","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2020.100139_bib18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12072-017-9814-1","article-title":"Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damage","volume":"11","author":"Saha","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2020.100139_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.dld.2007.08.006","article-title":"Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure","volume":"39","author":"Di Campli","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2020.100139_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/liv.12415","article-title":"Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure","volume":"34","author":"Khanam","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2020.100139_bib21","first-page":"90","article-title":"Effects of granulocyte colony-stimulating factor on patients with liver failure: a meta-analysis","volume":"4","author":"Yang","year":"2016","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.jhepr.2020.100139_bib22","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1053\/j.gastro.2015.02.054","article-title":"Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis","volume":"148","author":"Kedarisetty","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2020.100139_bib23","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.29763","article-title":"Outcomes after multiple courses of granulocyte colony-stimulating factor and growth hormone in decompensated cirrhosis: a randomized trial","volume":"68","author":"Verma","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100139_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jhep.2006.02.018","article-title":"Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease","volume":"45","author":"Gaia","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100139_bib25","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.30516","article-title":"Efficacy of granulocyte colony-stimulating factor in the management of steroid-nonresponsive severe alcoholic hepatitis: a double-blind randomized controlled trial","volume":"70","author":"Shasthry","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100139_bib26","first-page":"A17","article-title":"Effect of granulocyte colony-stimulating factor (G-CSF) on mortality and complications viz. sepsis, encephalopathy, hepatorenal syndrome, and gastrointestinal bleed in severe alcoholic hepatitis: a randomized controlled study","volume":"5","author":"Sharma","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jhepr.2020.100139_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","article-title":"Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial","volume":"3","author":"Newsome","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2020.100139_bib28","article-title":"G-CST to treat ACLF (GRAFT TRIAL): interim analysis of the first randomised European multicentral trial","author":"Engelmann","year":"2019","journal-title":"AASLD"},{"key":"10.1016\/j.jhepr.2020.100139_bib29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jceh.2019.05.003","article-title":"Granulocyte colony-stimulating factor use in decompensated cirrhosis: lack of survival benefit and probable predisposition to hepatocellular carcinoma","volume":"10","author":"Philips","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jhepr.2020.100139_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jhepr.2020.100139_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1017\/S0266462300009570","article-title":"Assessing the quality of randomized controlled trials. Current issues and future directions","volume":"12","author":"Moher","year":"1996","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jhepr.2020.100139_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jhepr.2020.100139_bib33","series-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","author":"Deeks","year":"2005"},{"key":"10.1016\/j.jhepr.2020.100139_bib34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jhepr.2020.100139_bib35","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.jhepr.2020.100139_bib36","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study","volume":"109","author":"Singh","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100139_bib37","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/gutjnl-2014-308410","article-title":"Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis","volume":"64","author":"Dubuquoy","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2020.100139_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/liv.12356","article-title":"Beneficial role of G-CSF in acute-on-chronic liver failure: effects on liver regeneration, inflammation\/immunoparalysis or both?","volume":"34","author":"Gustot","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2020.100139_bib39","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/ajg.2014.250","article-title":"G-CSF therapy for severe alcoholic hepatitis: targeting liver regeneration or neutrophil function?","volume":"109","author":"Moreau","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100139_bib40","first-page":"7","article-title":"A\u00a0systematic literature review of the efficacy, effectiveness, and safety of filgrastim","volume":"26","author":"Dale","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jhepr.2020.100139_bib41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s13063-018-3092-7","article-title":"Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial","volume":"19","author":"Cho","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.jhepr.2020.100139_bib42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jhep.2018.10.041","article-title":"Alcohol-related liver disease: areas of consensus, unmet needs and opportunities for further study","volume":"70","author":"Thursz","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100139_bib43","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2004.05.019","article-title":"Evaluation of amantadine in chronic hepatitis C: a meta-analysis","volume":"41","author":"Deltenre","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100139_bib44","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/apt.13424","article-title":"Systematic review with meta-analysis: self-expanding metal stents\u00a0in patients with cirrhosis and severe or refractory oesophageal variceal bleeding","volume":"42","author":"Marot","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2020.100139_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2036.1998.00286.x","article-title":"Review article: overview of medical treatments in unresectable hepatocellular carcinoma\u2014an impossible meta-analysis?","volume":"12","author":"Mathurin","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2020.100139_bib46","first-page":"CD011389","article-title":"Laparoscopic versus open gastrectomy for gastric cancer","volume":"3","author":"Best","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhepr.2020.100139_bib47","first-page":"CD012918","article-title":"Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis","volume":"12","author":"Grace","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhepr.2020.100139_bib48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2036.2012.05197.x","article-title":"Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients","volume":"36","author":"Schreiber","year":"2012","journal-title":"Aliment Pharmacol Ther"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920300732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920300732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:24:31Z","timestamp":1762899871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555920300732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2589555920300732"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100139","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granulocyte colony-stimulating factor for alcoholic hepatitis: A\u00a0systematic review and meta-analysis of randomised controlled trials","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100139"}}